1. Home
  2. Business & Finance
  3. Markets
About.com

Markets

Powered by Financial Content
Markets
Stocks
Mutual Funds & ETF's
Sectors
Rates
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Threshold Continues Rising On Upbeat Trial Results
By: MarketMinute.com Stock News
Posted on February 22, 2012 at 16:56 PM EST

Shares of Threshold Pharmaceuticals Inc. (Nasdaq: THLD) continued rising by jumping $1.02 to close at $6.03 after reporting upbeat results from a midstage clinical trial of its pancreatic cancer treatment TH-302 yesterday.


Related Stocks:
Threshold Pharmaceuticals, Inc.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Mortgage Rates, CD Rates & Home Equity Rates provided by Banks.com
Press Release Service provided by PRConnect.
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
About.com
Markets
  1. Home
  2. Business & Finance
  3. Markets

©2012 About.com. The New York Times Company.